Kona Medical announced three and six month results from the WAVE I study, a first-in-man study evaluating the safety and efficacy of Kona Medical’s Surround Sound Renal Denervation System for the treatment of resistant hypertension.
CardioKinetix Inc. announced the transmission of a live satellite feed of a clinical case using the catheter-based Parachute Device. The Parachute procedure was performed by Dr. Martyn Thomas, M.D., chairman of cardiology at St. Thomas’ Hospital in London, England, with assistance from Dr. Hüseyin Ince, professor of medicine, University Hospital Rostock, Germany.
When a power outage occurs, MRI equipment can be damaged and accuracy of the scans effected. To mitigate the effects of power interruptions, healthcare facilities have traditionally relied on the lead-acid batteries of uninterruptible power supplies (UPSs) to provide backup power. However, batteries are notorious for their reliability issues, large footprint and frequent maintenance and replacement.
If you enjoy this content, please share it with a colleague
Today’s healthcare is changing in many ways and so are the processes, technology and people delivering the extremely complex cardiology procedures and services. There are multiple biomedical and technical advances that are proving to optimize patient care. With declining budgets and reimbursements, healthcare providers are under increasing pressure to develop effective ways of improving efficiency and reducing costs, while maintaining high levels of patient care.Â
If you enjoy this content, please share it with a colleague
Cardiovascular Systems Inc. (CSI) has presented 30-day results from its ORBIT II study of coronary artery disease. ORBIT II is evaluating the safety and effectiveness of the company’s orbital atherectomy technology in treating patients with severely calcified coronary lesions. This is the first Investigational Device Exemption study to evaluate this problematic subset of patients. CSI completed ORBIT II enrollment of 443 patients at 49 U.S. medical centers in November 2012 and submitted its Premarket Approval application to the U.S. Food and Drug Administration (FDA) on March 15, 2013.
If you enjoy this content, please share it with a colleague
Transradial coronary artery angiography was a major focus at the Society for Cardiovascular Angiography Interventions (SCAI) 2013 Scientific Sessions May 8-11 in Orlando, Fla. The meeting kicked-off with a dedicated symposium covering topics such as access, radiation exposure and complications.
If you enjoy this content, please share it with a colleague
Philips Healthcare announced that CX50 xMatrix, the first portable ultrasound with Philips' Live 3-D Â transesophageal echo (TEE), now offers 2-DÂ intracardiac echo (ICE)Â capability. The CX50 xMatrix with available Live 3-D TEE and ICE was first shown in Paris at the EuroPCR in May.